NCT00692250
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
- Locations
-
- University Medical Center Groningen- Biotech Center Groningen, Netherlands
Clinical trial condition
Lipid Metabolism Disorders
Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.
3,310 public trials
329 recruiting studies
Lipid Metabolism Disorders trial results
NCT01486433
- Conditions
- Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +3 more
- Locations
-
- Tempe, Arizona, United States
NCT00677313
- Conditions
- Diabetes Mellitus, Dyslipidemias, Endocrine System Diseases, +10 more
- Locations
-
- Research Site Santa Barbara, California, United States
- Research Site Chicago, Illinois, United States
- Research Site Ann Arbor, Michigan, United States
- Local Institution Reno, Nevada, United States
NCT01581372
- Conditions
- Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases, +1 more
- Locations
-
- Safeway Calgary, Alberta, Canada
- London Drugs Lethbridge, Alberta, Canada
NCT01597843
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +15 more
- Locations
-
- Clement J. Zablocki VA Medical Center, Milwaukee, WI Milwaukee, Wisconsin, United States
- Conditions
- Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +3 more
- Locations
-
- Tempe, Arizona, United States
NCT00321789
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Durham VA Medical Center, Durham, NC Durham, North Carolina, United States
NCT00136981
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
- Locations
-
- Pfizer Investigational Site Hartford, Connecticut, United States
- Pfizer Investigational Site Boston, Massachusetts, United States
- Pfizer Investigational Site Minneapolis, Minnesota, United States
- Pfizer Investigational Site New York, United States
NCT02422927
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +11 more
- Locations
-
Not specified
Completed
A Study of the Kinetics of a 13C-Cholesterol Infusate in Healthy Male Subjects (0000-108)(COMPLETED)
NCT01101763
- Conditions
- Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
- Locations
-
Not specified